Alendronic acid versus teriparatide in women with postmenopausal osteoporosis
Phase of Trial: Phase III
Latest Information Update: 20 Dec 2011
At a glance
- Drugs Alendronic acid; Teriparatide
- Indications Fracture; Postmenopausal osteoporosis
- Focus Pharmacodynamics
- Acronyms FACT
- Sponsors Eli Lilly
- 20 Dec 2011 Not official study title
- 08 Nov 2011 Results of an analysis of bone remodelling parameters (n=21) presented at the 14th Annual European Conference of the International Society for Pharmacoeconomics and Outcomes Research.
- 05 Nov 2010 New trial record.